Source: PR Newswire

Press Release: Affera : Affera's Technology for Cardiac Arrhythmia Treatment Highlighted at the 2020 Heart Rhythm Society Late-Breaking Clinical Trial Session and Three Simultaneous Publications

/PRNewswire/ -- Affera, Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that its platform...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Doron Harlev's photo - Founder & CEO of Affera

Founder & CEO

Doron Harlev

CEO Approval Rating

90/100

Read more